HKPD · Company research

Cellyan Biotechnology Co., Ltd Class A Ordinary Shares (HKPD): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

16records availableHealthcare

Stock News & Events data

Database-backed records only

16 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
HKPD: Hong Kong Pharma Digital Technology Holdings Ltd. Latest Stock Price, Analysis, News and Trading Ideas - StocktwitsHKPD: Hong Kong Pharma Digital Technology Holdings Ltd. Latest Stock Price, Analysis, News and Trading Ideas StocktwitsView source ↗StocktwitsOct 9, 2026neutral00.6
Cellyan Biotechnology Shareholders Approve 1-for-20 Consolidation and Charter Overhaul - The Globe and MailCellyan Biotechnology Shareholders Approve 1-for-20 Consolidation and Charter Overhaul The Globe and MailView source ↗The Globe and MailSep 24, 2026neutral00.6
Cellyan Biotechnology (HKPD) Advances 3.61% as Shares Approach Key $0.44 Resistance - Corrective Wave - www.dars.gov.etCellyan Biotechnology (HKPD) Advances 3.61% as Shares Approach Key $0.44 Resistance - Corrective Wave www.dars.gov.etView source ↗www.dars.gov.etAug 12, 2026neutral00.6
Cellyan Biotechnology (HKPD) Advances 3.61% as Shares Approach Key $0.44 Resistance - AAII Neutral - https://www.dars.gov.et/Cellyan Biotechnology (HKPD) Advances 3.61% as Shares Approach Key $0.44 Resistance - AAII Neutral https://www.dars.gov.et/View source ↗https://www.dars.gov.et/Aug 12, 2026neutral00.6
Cellyan Biotechnology Receives Nasdaq Extension to Regain Minimum Bid Price Compliance | HKPD Stock News - Quiver QuantitativeCellyan Biotechnology Receives Nasdaq Extension to Regain Minimum Bid Price Compliance | HKPD Stock News Quiver QuantitativeView source ↗Quiver QuantitativeJul 16, 2026neutral00.6
Cellyan Biotechnology (Nasdaq:HKPD) - Stock Analysis - Simply Wall StreetCellyan Biotechnology (Nasdaq:HKPD) - Stock Analysis Simply Wall StreetView source ↗Simply Wall StreetJan 3, 2026neutral00.6
Hong Kong Pharma Digital Technology Holdings Ltd. (HKPD) Live Share Price, Invest From India - INDmoneyHong Kong Pharma Digital Technology Holdings Ltd. (HKPD) Live Share Price, Invest From India INDmoneyView source ↗INDmoneyApr 18, 2025neutral00.6
symbol__ Stock Quote Price and Forecast - CNNsymbol__ Stock Quote Price and Forecast CNNView source ↗CNNJan 24, 2025neutral00.6
symbol__ Stock Quote Price and Forecast - CNNsymbol__ Stock Quote Price and Forecast CNNView source ↗CNNJan 24, 2025neutral00.6
HKPD Sentiment - StocktwitsHKPD Sentiment StocktwitsView source ↗StocktwitsJan 18, 2025neutral00.6
HKPD Stock Price and Chart — NASDAQ:HKPD - TradingViewHKPD Stock Price and Chart — NASDAQ:HKPD TradingViewView source ↗TradingViewJan 15, 2025neutral00.6
Cellyan Biotechnology Co., Ltd Class A Ordinary Shares (HKPD) Historical Quotes - NasdaqCellyan Biotechnology Co., Ltd Class A Ordinary Shares (HKPD) Historical Quotes NasdaqView source ↗NasdaqJan 15, 2025neutral00.6
Cellyan Biotechnology Co., Ltd (HKPD) Stock Major Holders - Yahoo! Finance CanadaCellyan Biotechnology Co., Ltd (HKPD) Stock Major Holders Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaJan 15, 2025neutral00.6
Cellyan Biotechnology Co., Ltd (HKPD) stock price, news, quote and history - Yahoo Finance UKCellyan Biotechnology Co., Ltd (HKPD) stock price, news, quote and history Yahoo Finance UKView source ↗Yahoo Finance UKJan 15, 2025neutral00.6
Cellyan Biotechnology Co., Ltd (HKPD) stock price, news, quote and history - Yahoo Finance SingaporeCellyan Biotechnology Co., Ltd (HKPD) stock price, news, quote and history Yahoo Finance SingaporeView source ↗Yahoo Finance SingaporeJan 15, 2025neutral00.6
Cellyan Biotechnology Co., Ltd (HKPD) Stock Price, News, Quote & History - Yahoo! Finance CanadaCellyan Biotechnology Co., Ltd (HKPD) Stock Price, News, Quote & History Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaJan 15, 2025neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.